Comparing preference for and use of medication abortion in Texas after policy changes in 2014 and 2018.

ABSTRACT:

Objectives

Assess preferences for and use of medication abortion in Texas after implementation of two policy changes: a 2013 state law restricting medication abortion and the FDA label change for mifepristone in 2016 nullifying some of this restriction.

Study design

We analyzed surveys conducted in 2014 and 2018 with abortion patients at 10 Texas abortion facilities. We calculated the percentage of all respondents with an initial preference for medication abortion by survey year, and the type of abortion obtained or planned to obtain among those who were at <10 weeks of gestation. We used multivariable-adjusted mixed-effects Poisson regression models to assess factors associated with medication abortion preference and actual/planned use.

Results

Overall, 156 (41%) of

SUBMITTER: Baum SE 

PROVIDER: S-EPMC9985975 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature